Document:

T3 8K Ex 10.5 Nonstatutory SOA

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS OF FEDERAL AND STATE SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION AND QUALIFICATION UNDER FEDERAL AND STATE SECURITIES LAWS IS NOT REQUIRED.

TRINITY3 CORPORATION

2004 OMNIBUS SECURITIES AND STOCK OPTION PLAN

 

NONSTATUTORY STOCK OPTION AGREEMENT

Trinity3 Corporation (the “Company”), hereby grants an Option to purchase shares of its common stock (“Shares”) to the Optionee named below. The terms and conditions of the Option are set forth in this cover sheet, in the attachment and in the Company’s 2004 Omnibus Securities and Stock Option Plan (the “Plan”).

Date of Grant:                                        
 

Name of Optionee:                                                                       

 

Optionee’s Social Security Number:                                             

 

Number of Shares Covered by Option:                                                        

               

Exercise Price per Share: $                                          

 

Vesting Start Date:                                                  

___   Check here if Optionee is a 10% owner (so that exercise price must be 100% of fair market value).

 

By signing this cover sheet, you agree to all of the terms and conditions described in the attached Agreement and in the Plan, a copy of which is also attached.

 

Optionee:                   

(Signature)

 

Company:                   

(Signature)

 

Title:                                                         

 

	 
	 	1	 
	

	 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS OF FEDERAL AND STATE SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION AND QUALIFICATION UNDER FEDERAL AND STATE SECURITIES LAWS IS NOT REQUIRED.

TRINITY3 CORPORATION

2004 OMNIBUS SECURITIES AND STOCK OPTION PLAN

NONSTATUTORY STOCK OPTION AGREEMENT

	
Nonstatutory Stock Option
	
This Option is not intended to be an incentive stock option under section 422 of the Internal Revenue Code and will be interpreted accordingly.

 

	
Vesting
	
No Shares will vest until you have performed _______ (____) months of Service from the commencement of your employment with the Company. Your Option shall vest as to _______ of the Shares on the date _______ (____) months from the Vesting Start Date as shown on the cover sheet. Thereafter, Shares shall vest at the rate of ________ of the Shares at the end of each full month thereafter. After you have completed ________ (____) months of Service, the number of Shares which vest under this Option at the Exercise Price shall be equal to the product of the number of full months of your continuous employment with the Company (“Service”) (including any approved leaves of absence) from the Vesting Start Date times the number of Shares covered by this Option times ________. The resulting number of Shares will be rounded to the nearest whole number. No additional Shares will vest after your Service has terminated for any reason.

You should note that you may exercise the Option prior to vesting. In that case, the Company has a right to repurchase the unvested shares at the original exercise price if you terminate employment before vesting in all shares you purchased. Also, if you exercise before vesting, you should consider making an 83(b) election. Please see the attached Tax Summary. The 83(b) election must be filed within 30 days of the date you exercise.

 

	
Term
	
Your Option will expire in any event at the close of business at Company headquarters on the day before the tenth anniversary of the Date of Grant, as shown on the cover sheet. (It will expire earlier if your Service terminates, as described below.)

 

 

 

	 
	 	2	 
	

	 

 

 

	 	 
	
Regular Termination
	
If your Service terminates for any reason except death, Disability, or for “Cause” your Option will expire at the close of business at Company headquarters on the 30th day after your termination date. During such 30-day period, you may exercise that portion of your Option that was vested on your termination date.

 

	
Death
	
If you die while in Service with the Company, your Option will expire at the close of business at Company headquarters on the date six months after the date of death. During that six-month period, your estate or heirs may exercise that portion of your Option that was vested on your date of death.

 

	
Disability
	
If your Service terminates because of your Disability, your Option will expire at the close of business at Company headquarters on the date six months after your termination date. During that six-month period, you may exercise that portion of your Option that was vested on your date of Disability.

 

“Disability” means that you are unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment.

 

	
Leaves of Absence
	
For purposes of this Option, your Service does not terminate when you go on a bona fide leave of absence that was approved by the Company in writing, if the terms of the leave provide for continued service crediting, or when continued service crediting is required by applicable law. However, your Service will be treated as terminating 30 days after you went on leave, unless your right to return to work is guaranteed by law or by a contract. Your service terminates in any event when the approved leave ends unless you immediately return to Service. The Company determines which leaves count for this purpose, and when your Service terminates for all purposes under the Plan. The Company also determines the extent to which you may exercise the vested portion of your Option during a leave of absence.

 

	
Notice of Exercise
	
When you wish to exercise this Option, you must execute Exhibit A (and if exercise is prior to vesting you must also execute Exhibits B and D). Your Exercise will be effective when it is received by the Company. If someone else wants to exercise this Option after your death, that person must prove to the Company’s satisfaction that he or she is entitled to do so.

 

 

	 
	 	3	 
	

	 

 

 

	 	 
	
Form of Payment
	
When you submit Exhibit A, you must include payment of the Exercise Price for the Shares you are purchasing. Payment may be made in one (or a combination) of the following forms at the discretion of the committee:

 

·   Your personal check, a cashier’s check or a money order.

·   Shares which you have owned for six months and which are surrendered to the Company. The value of the Shares, determined as of the effective date of the Option exercise, will be applied to the Exercise Price.

·   To the extent that a public market for the Shares exists as determined by the Company, by delivery (on a form prescribed by the Committee) of an irrevocable direction to a securities broker to sell Shares and to deliver all or part of the sale proceeds to the Company in payment of the aggregate Exercise Price.

·   Any other form of legal consideration approved by the Committee.

 

	
Withholding Taxes
	
You will not be allowed to exercise this Option unless you make acceptable arrangements to pay any withholding or other taxes that may be due as a result of the Option exercise or the sale of Shares acquired upon exercise of this Option.

 

	
Restrictions on Resale
	
By signing this Agreement, you agree not to exercise this Option or sell any Shares acquired upon exercise of this Option at a time when applicable laws, regulations or Company or underwriter trading policies prohibit exercise or sale. In particular, the Company shall have the right to designate one or more periods of time, each of which shall not exceed 180 days in length, during which this Option shall not be exercisable if the Company determines (in its sole discretion) that such limitation on exercise could in any way facilitate a lessening of any restriction on transfer pursuant to the Securities Act or any state securities laws with respect to any issuance of securities by the Company, facilitate the registration or qualification of any securities by the Company under the Securities Act or any state securities laws, or facilitate the perfection of any exemption from the registration or qualification requirements of the Securities Act or any applicable state securities laws for the issuance or transfer of any securities. Such limitation on exercise shall not alter the vesting schedule set forth in this Agreement other than to limit the periods during which this Option shall be exercisable.

 

Furthermore, in respect of any underwritten public offering by the Company, you agree that you will not sell or otherwise transfer or dispose of any Shares covered by this Option during a reasonable and customary period of time as agreed to by the Company and the underwriters, not to exceed the greater of (a) 180 days following the effective date of the registration statement of the Company filed under the Securities Act in respect of such offering and (b) such other period of time as agreed to by holders of a majority of the then outstanding Shares. By signing this Agreement you agree to execute and deliver such other agreements as may be reasonably requested by the Company or the underwriter which are consistent with the foregoing or which are necessary to give further effect thereto. The Company may impose stop-transfer instructions with respect to the Shares subject to the foregoing restriction until the end of such period.

If the sale of Shares under the Plan is not registered under the Securities Act of 1933, as amended (the “Securities Act”), but an exemption is available which requires an investment or other representation, you shall represent and agree at the time of exercise that the Shares being acquired upon exercise of this Option are being acquired for investment, and not with a view to the sale or distribution thereof, and shall make such other representations as are deemed necessary or appropriate by the Company and its counsel.

 

 

	 
	 	4	 
	

	 

 

 

	 	 
	
The Company’s Right of First Refusal
	
In the event that you propose to sell, pledge or otherwise transfer to a third party any Shares acquired under this Agreement, or any interest in such Shares, the Company shall have the “Right of First Refusal” with respect to all (and not less than all) of such Shares. If you desire to transfer Shares acquired under this Agreement, you must give a written “Transfer Notice” to the Company describing fully the proposed transfer, including the number of Shares proposed to be transferred, the proposed transfer price and the name and address of the proposed transferee. The Transfer Notice shall be signed both by you and by the proposed transferee and must constitute a binding commitment of both parties to the transfer of the Shares.

 

The Company and its assignees shall have the right to purchase all, and not less than all, of the Shares on the terms described in the Transfer Notice (subject, however, to any change in such terms permitted in the next paragraph) by delivery of a notice of exercise of the Right of First Refusal within 30 days after the date when the Transfer Notice was received by the Company. 

 

The Company’s rights under this Subsection shall be freely assignable, in whole or in part.

If the Company fails to exercise its Right of First Refusal within 30 days after the date when it received the Transfer Notice, you may, not later than 60 days following receipt of the Transfer Notice by the Company, conclude a transfer of the Shares subject to the Transfer Notice on the terms and conditions described in the Transfer Notice. Any proposed transfer on terms and conditions different from those described in the Transfer Notice, as well as any subsequent proposed transfer by you, shall again be subject to the Right of First Refusal and shall require compliance with the procedure described in the paragraph above. If the Company exercises its Right of First Refusal, you and the Company (or its assignees) shall consummate the sale of the Shares on the terms set forth in the Transfer Notice.

The Company’s Right of First Refusal shall inure to the benefit of its successors and assigns and shall be binding upon any transferee of the Shares. 

 

 

 

	 
	 	5	 
	

	 

 

 

	 	 
	
Right of Repurchase
	
Following termination of your Service for any reason, the Company shall have the right to purchase all of those vested Shares that you have or will acquire under this Option (unvested Shares which have been exercised are subject to a Repurchase Option set forth in Exhibit A). If the Company fails to provide you with written notice of its intention to purchase such Shares before or within 30 days of the date the Company receives written notice from you of your termination of Service, the Company’s right to purchase such Shares shall terminate. If the Company exercises its right to purchase such Shares, the Company will consummate the purchase of such Shares within 60 days of the date of its written notice to you. The purchase price for any Shares repurchased shall be the higher of the fair market value of the Shares on the date of purchase or the aggregate Exercise Price for such Shares and shall be paid in cash. The Company’s right of repurchase shall terminate in the event that Stock is listed on an established stock exchange or is quoted regularly on the Nasdaq National Market. The fair market value shall be determined by the Board of Directors in its sole discretion.

 

	
Transfer of Option
	
Prior to your death, only you may exercise this Option. You cannot transfer or assign this Option. For instance, you may not sell this Option or use it as security for a loan. If you attempt to do any of these things, this Option will immediately become invalid. You may, however, dispose of this Option in your will.

Regardless of any marital property settlement agreement, the Company is not obligated to honor a Notice of Exercise from your spouse or former spouse, nor is the Company obligated to recognize such individual’s interest in your Option in any other way. 

 

 

	 
	 	6	 
	

	 

 

 

	 	 
	
Retention Rights
	
This Agreement does not give you the right to be retained by the Company in any capacity. The Company reserves the right to terminate your Service at any time and for any reason.

 

	
Shareholder Rights
	
Neither you, nor your estate or heirs, have any rights as a shareholder of the Company until a certificate for the Shares acquired upon exercise of this Option has been issued. No adjustments are made for dividends or other rights if the applicable record date occurs before your stock certificate is issued, except as described in the Plan.

 

	
Adjustments
	
In the event of a stock split, a stock dividend or a similar change in the Company Stock, the number of Shares covered by this Option and the Exercise Price per share may be adjusted pursuant to the Plan. Your Option shall be subject to the terms of the agreement of merger, liquidation or reorganization in the event the Company is subject to such corporate activity.

 

	
Legends
	
All certificates representing the Shares issued upon exercise of this Option shall, where applicable, have endorsed thereon the following legends:

 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND OPTIONS TO PURCHASE SUCH SHARES SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER, OR SUCH HOLDER’S PREDECESSOR IN INTEREST. SUCH AGREEMENT IMPOSES CERTAIN TRANSFER RESTRICTIONS AND GRANTS CERTAIN REPURCHASE RIGHTS TO THE COMPANY (OR ITS ASSIGNS) UPON THE SALE OF THE SHARES OR UPON TERMINATION OF SERVICE WITH THE COMPANY. A COPY OF SUCH AGREEMENT IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY AND WILL BE FURNISHED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY BY THE HOLDER OF SHARES REPRESENTED BY THIS CERTIFICATE.

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, OR THE SECURITIES LAWS OF ANY STATE, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS OF FEDERAL AND STATE SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT REGISTRATION AND QUALIFICATION UNDER FEDERAL AND STATE SECURITIES LAWS IS NOT REQUIRED.” 

 

 

 

	 
	 	7	 
	

	 

 

 

	 	 
	
Applicable Law
	
This Agreement will be interpreted and enforced under the laws of the State of California (without regard to their choice of law provisions).

 

	
The Plan and Other Agreements
	
The text of the Plan is incorporated in this Agreement by reference. Certain capitalized terms used in this Agreement are defined in the Plan.

 

This Agreement and the Plan constitute the entire understanding between you and the Company regarding this Option. Any prior agreements, commitments or negotiations concerning this Option are superseded.

 

By signing the cover sheet of this Agreement, you agree to all of the terms and conditions described above and in the Plan. You also acknowledge that you have read Section 11, “Purchaser’s Investment Representations” of Attachment A and that you can and hereby do make the same representations with respect to the grant of this Option

	 
	 	8Exhibit 10.1

                          GVI SECURITY SOLUTIONS, INC.

                          SECURITIES PURCHASE AGREEMENT

                                  MAY 27, 2004

<PAGE>

                                TABLE OF CONTENTS
                                                                            PAGE
                                                                            ----

1.       Agreement to Sell and Purchase........................................2

2.       Fees and Warrant......................................................3

3.       Closing, Delivery and Payment.........................................4
         3.1        Closing....................................................4
         3.2        Delivery...................................................4

4.       Representations and Warranties of the Company.........................5
         4.1        Organization, Good Standing and Qualification..............5
         4.2        Subsidiaries...............................................7
         4.3        Capitalization; Voting Rights..............................7
         4.4        Authorization; Binding Obligations.........................9
         4.5        Liabilities...............................................11
         4.6        Agreements; Action........................................11
         4.7        Obligations to Related Parties............................13
         4.8        Changes...................................................14
         4.9        Title to Properties and Assets; Liens, Etc................17
         4.10       Intellectual Property.....................................18
         4.11       Compliance with Other Instruments.........................19
         4.12       Litigation................................................19
         4.13       Tax Returns and Payments..................................19
         4.14       Employees.................................................19
         4.15       Registration Rights and Voting Rights.....................19
         4.16       Compliance with Laws; Permits.............................19
         4.17       Environmental and Safety Laws.............................19
         4.18       Valid Offering............................................19
         4.19       Full Disclosure...........................................19
         4.20       Insurance.................................................19
         4.21       SEC Reports...............................................19
         4.22       No Integrated Offering....................................19
         4.23       Stop Transfer.............................................19
         4.24       Dilution..................................................19
         4.25       Patriot Act...............................................19

5.       Representations and Warranties of the Purchaser......................19
         5.1        No Shorting...............................................19
         5.2        Requisite Power and Authority.............................19
         5.3        Investment Representations................................19
         5.4        Purchaser Bears Economic Risk.............................19
         5.5        Acquisition for Own Account...............................19
         5.6        Purchaser Can Protect Its Interest........................19
         5.7        Accredited Investor.......................................19
         5.8        Legends...................................................19

                                      -i-
<PAGE>

6.       Covenants of the Company.............................................19
         6.1        Stop-Orders...............................................19
         6.2        Listing...................................................19
         6.3        Market Regulations........................................19
         6.4        Reporting Requirements....................................19
         6.5        Use of Funds..............................................19
         6.6        Access to Facilities......................................19
         6.7        Taxes.....................................................19
         6.8        Insurance.................................................19
         6.9        Intellectual Property.....................................19
         6.10       Properties................................................19
         6.11       Confidentiality...........................................19
         6.12       Required Approvals........................................19
         6.13       Reissuance of Securities..................................19
         6.14       Opinion...................................................19
         6.15       Margin Stock..............................................19

7.       Covenants of the Purchaser...........................................19
         7.1        Confidentiality...........................................19
         7.2        No Short Sales............................................19
         7.3        Non-Public Information....................................19

8.       Covenants of the Company and Purchaser Regarding Indemnification.....19
         8.1        Company Indemnification...................................19
         8.2        Purchaser's Indemnification...............................19
         8.3        Procedures................................................19

9.       Conversion of Convertible Note.......................................19
         9.1        Mechanics of Conversion...................................19

10.      Registration Rights..................................................19
         10.1       Registration Rights Granted...............................19
         10.2       Offering Restrictions.....................................19

11.      Miscellaneous........................................................19
         11.1       Governing Law.............................................19
         11.2       Survival..................................................19
         11.3       Successors................................................19
         11.4       Entire Agreement..........................................19
         11.5       Severability..............................................19
         11.6       Amendment and Waiver......................................19
         11.7       Delays or Omissions.......................................19
         11.8       Notices...................................................19
         11.9       Attorneys' Fees...........................................19
         11.10      Titles and Subtitles......................................19
         11.11      Facsimile Signatures; Counterparts........................19
         11.12      Broker's Fees.............................................19
         11.13      Construction..............................................19

                                      -ii-
<PAGE>

                                LIST OF EXHIBITS
--------------------------------------------------------------------------------
Form of Convertible Term Note..........................................Exhibit A
Form of Warrant........................................................Exhibit B
Form of Opinion........................................................Exhibit C
Form of Escrow Agreement...............................................Exhibit D

                                      -iii-
<PAGE>

                          SECURITIES PURCHASE AGREEMENT

      THIS SECURITIES PURCHASE AGREEMENT (this "Agreement") is made and entered
into as of May 27, 2004, by and between GVI SECURITY SOLUTIONS, INC., a Delaware
corporation (the "Company"), and Laurus Master Fund, Ltd., a Cayman Islands
company (the "Purchaser").

                                    RECITALS

      WHEREAS, the Company has authorized the sale to the Purchaser of a
Convertible Term Note in the aggregate principal amount of Five Million Dollars
($5,000,000) (the "Note"), which Note is convertible into shares of the
Company's common stock, $0.001 par value per share (the "Common Stock") at an
initial fixed conversion price of $2.70 per share of Common Stock ("Fixed
Conversion Price");

      WHEREAS, the Company wishes to issue a warrant to the Purchaser to
purchase up to 940,000 shares of the Company's Common Stock (subject to
adjustment as set forth therein) in connection with Purchaser's purchase of the
Note;

      WHEREAS, Purchaser desires to purchase the Note and the Warrant (as
defined in Section 2) on the terms and conditions set forth herein; and

      WHEREAS, the Company desires to issue and sell the Note and Warrant to
Purchaser on the terms and conditions set forth herein.

                                    AGREEMENT

      NOW, THEREFORE, in consideration of the foregoing recitals and the mutual
promises, representations, warranties and covenants hereinafter set forth and
for other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties hereto agree as follows:

      1. Agreement to Sell and Purchase. Pursuant to the terms and conditions
set forth in this Agreement, on the Closing Date (as defined in Section 3), the
Company agrees to sell to the Purchaser, and the Purchaser hereby agrees to
purchase from the Company, a Note in the aggregate principal amount of Five
Million Dollars ($5,000,000) convertible into shares of the Company's Common
Stock in accordance with the terms of the Note and this Agreement. The sale to
the Purchaser of the Note and Warrant on the Closing Date shall be known as the
"Offering." A form of the Note is annexed hereto as Exhibit A. The Note will
mature on the Maturity Date (as defined in the Note). Collectively, the Note and
Warrant and Common Stock issuable in payment of the Note, upon conversion of the
Note and upon exercise of the Warrant are referred to as the "Securities."

      2. Fees and Warrant. On the Closing Date:

            (a) The Company will issue and deliver to the Purchaser a Warrant to
      purchase up to 940,000 shares of Common Stock in connection with the
      Offering (the "Warrant") pursuant to Section 1 hereof. The Warrant must be
      delivered on the Closing Date. A form of Warrant is annexed hereto as
      Exhibit B. All the representations, covenants, warranties, undertakings,
      and indemnification, and other rights made or granted to or for the
      benefit of the Purchaser by the Company are hereby also made and granted
      in respect of the Warrant and shares of the Company's Common Stock
      issuable upon exercise of the Warrant (the "Warrant Shares").

<PAGE>

            (b) Subject to the terms of Section 2(d) below, the Company shall
      pay to Laurus Capital Management, LLC, the manager of the Purchaser, a
      closing payment in an amount equal to three and nine-tenths of one percent
      (3.90%) of the aggregate principal amount of the Note. The foregoing fee
      is referred to herein as the "Closing Payment."

            (c) The Company shall reimburse the Purchaser for its reasonable
      legal fees for services rendered to the Purchaser in preparation of this
      Agreement and the Related Agreements (as hereinafter defined), and
      expenses incurred in connection with the Purchaser's due diligence review
      of the Company and its Subsidiaries (as defined in Section 4.2) and all
      related matters. Amounts required to be paid under this Section 2(c) (the
      "Transaction Expenses") will be paid on the Closing Date and shall not
      exceed $52,500 for fees and for expenses incurred while performing due
      diligence inquiries on the Company and its Subsidiaries.

            (d) The Closing Payment and the Transaction Expenses (net of
      deposits previously paid by the Company) shall be paid at closing out of
      funds held pursuant to a Funds Escrow Agreement of even date herewith
      among the Company, Purchaser, and an Escrow Agent (the "Funds Escrow
      Agreement") and a disbursement letter (the "Disbursement Letter").

      3. Closing, Delivery and Payment.

            3.1 Closing. Subject to the terms and conditions herein, the closing
of the transactions contemplated hereby (the "Closing"), shall take place on the
date hereof, at such time or place as the Company and Purchaser may mutually
agree (such date is hereinafter referred to as the "Closing Date").

            3.2 Delivery. Pursuant to the Funds Escrow Agreement in the form
attached hereto as Exhibit D, at the Closing on the Closing Date, the Company
will deliver to the Purchaser, among other things, a Note in the form attached
as Exhibit A in the principal amount of $5,000,000 and a Warrant in the form
attached as Exhibit B in the Purchaser's name representing the right to purchase
940,000 Warrant Shares and the Purchaser will deliver to the Company, among
other things, the amounts set forth in the Disbursement Letter by certified
funds or wire transfer.

      4. Representations and Warranties of the Company. The Company hereby
represents and warrants to the Purchaser as follows (which representations and
warranties are supplemented by the Company's filings under the Securities
Exchange Act of 1934 (collectively, the "Exchange Act Filings")):

                                       2
<PAGE>

            4.1 Organization, Good Standing and Qualification. Each of the
Company and each of its Subsidiaries is a corporation, partnership or limited
liability company, as the case may be, duly organized, validly existing and in
good standing under the laws of its jurisdiction of organization. Each of the
Company and each of its Subsidiaries, as applicable, has the corporate power and
authority to own and operate its properties and assets, to execute and deliver
(i) this Agreement, (ii) the Note and the Warrant to be issued in connection
with this Agreement, (iii) the Master Security Agreement dated as of the date
hereof between the Company, certain Subsidiaries of the Company and the
Purchaser (as amended, modified or supplemented from time to time, the "Master
Security Agreement"), (iv) the Registration Rights Agreement relating to the
Securities dated as of the date hereof between the Company and the Purchaser,
(v) the Subsidiary Guaranty dated as of the date hereof made by certain
Subsidiaries of the Company (as amended, modified or supplemented from time to
time, the "Subsidiary Guaranty"), (vi) the Stock Pledge Agreement dated as of
the date hereof among the Company and the Purchaser (as amended, modified or
supplemented from time to time, the "Stock Pledge Agreement"), (vii) the Escrow
Agreement dated as of the date hereof among the Company, the Purchaser and the
escrow agent referred to therein and (viii) all other agreements related to this
Agreement and the Note and referred to herein (the preceding clauses (ii)
through (viii), collectively, the "Related Agreements"), to issue and sell the
Note and the shares of Common Stock issuable upon conversion of the Note (the
"Note Shares"), to issue and sell the Warrant and the Warrant Shares, and to
carry out the provisions of this Agreement and the Related Agreements and to
carry on its business as presently conducted. Each of the Company and each of
its Subsidiaries is duly qualified and is authorized to do business and is in
good standing as a foreign corporation, partnership or limited liability
company, as the case may be, in all jurisdictions in which the nature of its
activities and of its properties (both owned and leased) makes such
qualification necessary, except for those jurisdictions in which failure to do
so has not, or could not reasonably be expected to have, individually or in the
aggregate, a material adverse effect on the business, assets, liabilities,
condition (financial or otherwise), properties, operations or prospects of the
Company and it Subsidiaries, taken individually and as a whole (a "Material
Adverse Effect").

            4.2 Subsidiaries. Each direct and indirect Subsidiary of the
Company, the direct owner of such Subsidiary and its percentage ownership
thereof, is set forth on Schedule 4.2. For the purpose of this Agreement, a
"Subsidiary" of any person or entity means (i) a corporation or other entity
whose shares of stock or other ownership interests having ordinary voting power
(other than stock or other ownership interests having such power only by reason
of the happening of a contingency) to elect a majority of the directors of such
corporation, or other persons or entities performing similar functions for such
person or entity, are owned, directly or indirectly, by such person or entity or
(ii) a corporation or other entity in which such person or entity owns, directly
or indirectly, more than 50% of the equity interests at such time.

      4.3 Capitalization; Voting Rights.

            (a) The authorized capital stock of the Company, as of the date
      hereof consists of 78,000,000 shares, of which 75,000,000 are shares of
      Common Stock, par value $0.001 per share, 29,603,750 shares of which are
      issued and outstanding, and 200 are shares of Series B Convertible
      Preferred Stock, par value $0.001 per share, all of which are issued and
      outstanding. The authorized capital stock of each Subsidiary of the
      Company is set forth on Schedule 4.3.

                                       3
<PAGE>

            (b) Except as disclosed on Schedule 4.3, other than: (i) the shares
      reserved for issuance under the Company's stock option plans; and (ii)
      shares which may be granted pursuant to this Agreement and the Related
      Agreements, there are no outstanding options, warrants, rights (including
      conversion or preemptive rights and rights of first refusal), proxy or
      stockholder agreements, or arrangements or agreements of any kind for the
      purchase or acquisition from the Company of any of its securities. Except
      as disclosed on Schedule 4.3, neither the offer, issuance or sale of any
      of the Note or the Warrant, or the issuance of any of the Note Shares or
      Warrant Shares, nor the consummation of any transaction contemplated
      hereby will result in a change in the price or number of any securities of
      the Company outstanding, under anti-dilution or other similar provisions
      contained in or affecting any such securities.

            (c) All issued and outstanding shares of the Company's Common Stock:
      (i) have been duly authorized and validly issued and are fully paid and
      nonassessable; and (ii) were issued in compliance with all applicable
      state and federal laws concerning the issuance of securities.

            (d) The rights, preferences, privileges and restrictions of the
      shares of the Common Stock are as stated in the Company's Certificate of
      Incorporation (the "Charter"). The Note Shares and Warrant Shares have
      been duly and validly reserved for issuance. When issued in compliance
      with the provisions of this Agreement and the Company's Charter, the
      Securities will be validly issued, fully paid and nonassessable, and will
      be free of any liens or encumbrances; provided, however, that the
      Securities may be subject to restrictions on transfer under state and/or
      federal securities laws as set forth herein or as otherwise required by
      such laws at the time a transfer is proposed.

            4.4 Authorization; Binding Obligations. All corporate, partnership
or limited liability company, as the case may be, action on the part of the
Company and each of its Subsidiaries (including the respective officers and
directors) necessary for the authorization of this Agreement and the Related
Agreements, the performance of all obligations of the Company and its
Subsidiaries hereunder and under the other Related Agreements at the Closing
and, the authorization, sale, issuance and delivery of the Note and Warrant has
been taken or will be taken prior to the Closing. This Agreement and the Related
Agreements, when executed and delivered and to the extent it is a party thereto,
will be valid and binding obligations of each of the Company and each of its
Subsidiaries, enforceable against each such person in accordance with their
terms, except:

            (a) as limited by applicable bankruptcy, insolvency, reorganization,
      moratorium or other laws of general application affecting enforcement of
      creditors' rights; and

            (b) general principles of equity that restrict the availability of
      equitable or legal remedies.

The sale of the Note and the subsequent conversion of the Note into Note Shares
are not and will not be subject to any preemptive rights or rights of first
refusal that have not been properly waived or complied with. The issuance of the
Warrant and the subsequent exercise of the Warrant for Warrant Shares are not
and will not be subject to any preemptive rights or rights of first refusal that
have not been properly waived or complied with.

                                       4
<PAGE>

            4.5 Liabilities. Neither the Company nor any of its Subsidiaries has
any contingent liabilities, except current liabilities incurred in the ordinary
course of business and liabilities disclosed in any Exchange Act Filings.

            4.6 Agreements; Action. Except as set forth on Schedule 4.6 or as
disclosed in any Exchange Act Filings:

            (a) there are no agreements, understandings, instruments, contracts,
      proposed transactions, judgments, orders, writs or decrees to which the
      Company or any of its Subsidiaries is a party or by which it is bound
      which may involve: (i) obligations (contingent or otherwise) of, or
      payments to, the Company in excess of $50,000 (other than obligations of,
      or payments to, the Company arising from purchase or sale agreements
      entered into in the ordinary course of business); or (ii) the transfer or
      license of any patent, copyright, trade secret or other proprietary right
      to or from the Company (other than licenses arising from the purchase of
      "off the shelf" or other standard products); or (iii) provisions
      restricting the development, manufacture or distribution of the Company's
      products or services; or (iv) indemnification by the Company with respect
      to infringements of proprietary rights.

            (b) Since December 31, 2003, neither the Company nor any of its
      Subsidiaries has: (i) declared or paid any dividends, or authorized or
      made any distribution upon or with respect to any class or series of its
      capital stock; (ii) incurred any indebtedness for money borrowed or any
      other liabilities (other than ordinary course obligations) individually in
      excess of $50,000 or, in the case of indebtedness and/or liabilities
      individually less than $50,000, in excess of $100,000 in the aggregate;
      (iii) made any loans or advances to any person not in excess, individually
      or in the aggregate, of $100,000, other than ordinary course advances for
      travel expenses; or (iv) sold, exchanged or otherwise disposed of any of
      its assets or rights, other than the sale of its inventory in the ordinary
      course of business.

            (c) For the purposes of subsections (a) and (b) above, all
      indebtedness, liabilities, agreements, understandings, instruments,
      contracts and proposed transactions involving the same person or entity
      (including persons or entities the Company has reason to believe are
      affiliated therewith) shall be aggregated for the purpose of meeting the
      individual minimum dollar amounts of such subsections.

            4.7 Obligations to Related Parties. Except as set forth on Schedule
4.6 or Schedule 4.7, there are no obligations of the Company or any of its
Subsidiaries to officers, directors, stockholders or employees of the Company or
any of its Subsidiaries other than:

            (a) for payment of salary for services rendered and for bonus
      payments;

            (b) reimbursement for reasonable expenses incurred on behalf of the
      Company and its Subsidiaries;

                                       5
<PAGE>

            (c) for other standard employee benefits made generally available to
      all employees (including stock option agreements outstanding under any
      stock option plan approved by the Board of Directors of the Company); and

            (d) obligations listed in the Company's financial statements or
      disclosed in any of its Exchange Act Filings.

Except as described above or set forth on Schedule 4.6 or Schedule 4.7, none of
the officers, directors or, to the best of the Company's knowledge, key
employees or stockholders of the Company or any members of their immediate
families, are indebted to the Company, individually or in the aggregate, in
excess of $50,000 or have any direct or indirect ownership interest in any firm
or corporation with which the Company is affiliated or with which the Company
has a business relationship, or any firm or corporation which competes with the
Company, other than passive investments in publicly traded companies
(representing less than one percent (1%) of such company) which may compete with
the Company. Except as described above, no officer, director or stockholder, or
any member of their immediate families, is, directly or indirectly, interested
in any material contract with the Company and no agreements, understandings or
proposed transactions are contemplated between the Company and any such person.
Except as set forth on Schedule 4.7, the Company is not a guarantor or
indemnitor of any indebtedness of any other person, firm or corporation.

      4.8 Changes. Since December 31, 2003, except as disclosed in any Exchange
Act Filing or in any Schedule to this Agreement or to any of the Related
Agreements, there has not been:

            (a) any change in the business, assets, liabilities, condition
      (financial or otherwise), properties, operations or prospects of the
      Company or any of its Subsidiaries, which individually or in the aggregate
      has had, or could reasonably be expected to have, individually or in the
      aggregate, a Material Adverse Effect;

            (b) any resignation or termination of any officer, key employee or
      group of employees of the Company or any of its Subsidiaries;

            (c) any material change, except in the ordinary course of business,
      in the contingent obligations of the Company or any of its Subsidiaries by
      way of guaranty, endorsement, indemnity, warranty or otherwise;

            (d) any damage, destruction or loss, whether or not covered by
      insurance, has had, or could reasonably be expected to have, individually
      or in the aggregate, a Material Adverse Effect;

            (e) any waiver by the Company or any of its Subsidiaries of a
      valuable right or of a material debt owed to it;

            (f) any direct or indirect loans made by the Company or any of its
      Subsidiaries to any stockholder, employee, officer or director of the
      Company or any of its Subsidiaries, other than advances made in the
      ordinary course of business;

                                       6
<PAGE>

            (g) any material change in any compensation arrangement or agreement
      with any employee, officer, director or stockholder of the Company or any
      of its Subsidiaries;

            (h) any declaration or payment of any dividend or other distribution
      of the assets of the Company or any of its Subsidiaries;

            (i) any labor organization activity related to the Company or any of
      its Subsidiaries;

            (j) any debt, obligation or liability incurred, assumed or
      guaranteed by the Company or any of its Subsidiaries, except those for
      immaterial amounts and for current liabilities incurred in the ordinary
      course of business;

            (k) any sale, assignment or transfer of any patents, trademarks,
      copyrights, trade secrets or other intangible assets owned by the Company
      or any of its Subsidiaries;

            (l) any change in any material agreement to which the Company or any
      of its Subsidiaries is a party or by which either the Company or any of
      its Subsidiaries is bound which either individually or in the aggregate
      has had, or could reasonably be expected to have, individually or in the
      aggregate, a Material Adverse Effect;

            (m) any other event or condition of any character that, either
      individually or in the aggregate, has had, or could reasonably be expected
      to have, individually or in the aggregate, a Material Adverse Effect; or

            (n) any arrangement or commitment by the Company or any of its
      Subsidiaries to do any of the acts described in subsection (a) through (m)
      above.

            4.9 Title to Properties and Assets; Liens, Etc. Except as set forth
on Schedule 4.9, each of the Company and each of its Subsidiaries has good and
marketable title to its properties and assets, and good title to its leasehold
estates, in each case subject to no mortgage, pledge, lien, lease, encumbrance
or charge, other than:

            (a) those resulting from taxes which have not yet become delinquent;

            (b) minor liens and encumbrances which do not materially detract
      from the value of the property subject thereto or materially impair the
      operations of the Company or any of its Subsidiaries; and

            (c) those that have otherwise arisen in the ordinary course of
      business.

All facilities, machinery, equipment, fixtures, vehicles and other properties
owned, leased or used by the Company and its Subsidiaries are in good operating
condition and repair and are reasonably fit and usable for the purposes for
which they are being used. Except as set forth on Schedule 4.9, the Company and
its Subsidiaries are in compliance with all material terms of each lease to
which it is a party or is otherwise bound.

            4.10 Intellectual Property. Except as set forth on Schedule 4.10:

                                       7
<PAGE>

            (a) Each of the Company and each of its Subsidiaries owns or
      possesses sufficient legal rights to all patents, trademarks, service
      marks, trade names, copyrights, trade secrets, licenses, information and
      other proprietary rights and processes necessary for its business as now
      conducted and to the Company's knowledge, as presently proposed to be
      conducted (the "Intellectual Property"), without any known infringement of
      the rights of others. There are no outstanding options, licenses or
      agreements of any kind relating to the foregoing proprietary rights, nor
      is the Company or any of its Subsidiaries bound by or a party to any
      options, licenses or agreements of any kind with respect to the patents,
      trademarks, service marks, trade names, copyrights, trade secrets,
      licenses, information and other proprietary rights and processes of any
      other person or entity other than such licenses or agreements arising from
      the purchase of "off the shelf" or standard products.

            (b) Neither the Company nor any of its Subsidiaries has received any
      communications alleging that the Company or any of its Subsidiaries has
      violated any of the patents, trademarks, service marks, trade names,
      copyrights or trade secrets or other proprietary rights of any other
      person or entity, nor is the Company or any of its Subsidiaries aware of
      any basis therefor.

            (c) The Company does not believe it is or will be necessary to
      utilize any inventions, trade secrets or proprietary information of any of
      its employees made prior to their employment by the Company or any of its
      Subsidiaries, except for inventions, trade secrets or proprietary
      information that have been rightfully assigned to the Company or any of
      its Subsidiaries.

            4.11 Compliance with Other Instruments. Neither the Company nor any
of its Subsidiaries is in violation or default of (x) any term of its Charter or
Bylaws, or (y) of any provision of any indebtedness, mortgage, indenture,
contract, agreement or instrument to which it is party or by which it is bound
(other than with respect to its indebtedness to Comerica Bank, which is to be
repaid at Closing) or of any judgment, decree, order or writ, which violation or
default, in the case of this clause (y), has had, or could reasonably be
expected to have, either individually or in the aggregate, a Material Adverse
Effect. The execution, delivery and performance of and compliance with this
Agreement and the Related Agreements to which it is a party, and the issuance
and sale of the Note by the Company and the other Securities by the Company each
pursuant hereto and thereto, will not, with or without the passage of time or
giving of notice, result in any such material violation, or be in conflict with
or constitute a default under any such term or provision, or result in the
creation of any mortgage, pledge, lien, encumbrance or charge upon any of the
properties or assets of the Company or any of its Subsidiaries or the
suspension, revocation, impairment, forfeiture or nonrenewal of any permit,
license, authorization or approval applicable to the Company, its business or
operations or any of its assets or properties.

            4.12 Litigation. Except as set forth on Schedule 4.12 hereto, there
is no action, suit, proceeding or investigation pending or, to the Company's
knowledge, currently threatened against the Company or any of its Subsidiaries
that prevents the Company or any of its Subsidiaries from entering into this
Agreement or the other Related Agreements, or from consummating the transactions
contemplated hereby or thereby, or which has had, or could reasonably be
expected to have, either individually or in the aggregate, a Material Adverse
Effect or any change in the current equity ownership of the Company or any of
its Subsidiaries, nor is the Company aware that there is any basis to assert any
of the foregoing. Neither the Company nor any of its Subsidiaries is a party or
subject to the provisions of any order, writ, injunction, judgment or decree of
any court or government agency or instrumentality. There is no action, suit,
proceeding or investigation by the Company or any of its Subsidiaries currently
pending or which the Company or any of its Subsidiaries intends to initiate.

                                       8
<PAGE>

            4.13 Tax Returns and Payments. Each of the Company and each of its
Subsidiaries has filed all tax returns (federal, state and local) required to be
filed by it. All taxes shown to be due and payable on such returns, any
assessments imposed, and all other taxes due and payable by the Company or any
of its Subsidiaries on or before the Closing, have been paid or will be paid
prior to the time they become delinquent. Except as set forth on Schedule 4.13,
neither the Company nor any of its Subsidiaries has been advised:

            (a) that any of its returns, federal, state or other, have been or
      are being audited as of the date hereof; or

            (b) of any deficiency in assessment or proposed judgment to its
      federal, state or other taxes.

The Company has no knowledge of any liability of any tax to be imposed upon its
properties or assets as of the date of this Agreement that is not adequately
provided for.

            4.14 Employees. Except as set forth on Schedule 4.14, neither the
Company nor any of its Subsidiaries has any collective bargaining agreements
with any of its employees. There is no labor union organizing activity pending
or, to the Company's knowledge, threatened with respect to the Company or any of
its Subsidiaries. Except as disclosed in the Exchange Act Filings or on Schedule
4.14, neither the Company nor any of its Subsidiaries is a party to or bound by
any currently effective employment contract, deferred compensation arrangement,
bonus plan, incentive plan, profit sharing plan, retirement agreement or other
employee compensation plan or agreement. To the Company's knowledge, no employee
of the Company or any of its Subsidiaries, nor any consultant with whom the
Company or any of its Subsidiaries has contracted, is in violation of any term
of any employment contract, proprietary information agreement or any other
agreement relating to the right of any such individual to be employed by, or to
contract with, the Company or any of its Subsidiaries because of the nature of
the business to be conducted by the Company or any of its Subsidiaries; and to
the Company's knowledge the continued employment by the Company or any of its
Subsidiaries of its present employees, and the performance of the Company's and
its Subsidiaries' contracts with its independent contractors, will not result in
any such violation. Neither the Company nor any of its Subsidiaries is aware
that any of its employees is obligated under any contract (including licenses,
covenants or commitments of any nature) or other agreement, or subject to any
judgment, decree or order of any court or administrative agency, that would
interfere with their duties to the Company or any of its Subsidiaries. Neither
the Company nor any of its Subsidiaries has received any notice alleging that
any such violation has occurred. Except for employees who have a current
effective employment agreement with the Company or any of its Subsidiaries, no
employee of the Company or any of its Subsidiaries has been granted the right to
continued employment by the Company or any of its Subsidiaries or to any
material compensation following termination of employment with the Company or
any of its Subsidiaries. Except as set forth on Schedule 4.14, the Company is
not aware that any officer, key employee or group of employees intends to
terminate his, her or their employment with the Company or any of its
Subsidiaries, nor does the Company or any of its Subsidiaries have a present
intention to terminate the employment of any officer, key employee or group of
employees.

                                       9
<PAGE>

            4.15 Registration Rights and Voting Rights. Except as set forth on
Schedule 4.15 and except as disclosed in Exchange Act Filings, neither the
Company nor any of its Subsidiaries is presently under any obligation, and
neither the Company nor any of its Subsidiaries has granted any rights, to
register any of the Company's or its Subsidiaries' presently outstanding
securities or any of its securities that may hereafter be issued. Except as set
forth on Schedule 4.15 and except as disclosed in Exchange Act Filings, to the
Company's knowledge, no stockholder of the Company or any of its Subsidiaries
has entered into any agreement with respect to the voting of equity securities
of the Company or any of its Subsidiaries.

            4.16 Compliance with Laws; Permits. Neither the Company nor any of
its Subsidiaries is in violation of any applicable statute, rule, regulation,
order or restriction of any domestic or foreign government or any
instrumentality or agency thereof in respect of the conduct of its business or
the ownership of its properties which has had, or could reasonably be expected
to have, either individually or in the aggregate, a Material Adverse Effect. No
governmental orders, permissions, consents, approvals or authorizations are
required to be obtained and no registrations or declarations are required to be
filed in connection with the execution and delivery of this Agreement or any
other Related Agreement and the issuance of any of the Securities, except such
as has been duly and validly obtained or filed, or with respect to any filings
that must be made after the Closing, as will be filed in a timely manner. Each
of the Company and its Subsidiaries has all material franchises, permits,
licenses and any similar authority necessary for the conduct of its business as
now being conducted by it, the lack of which could, either individually or in
the aggregate, reasonably be expected to have a Material Adverse Effect.

            4.17 Environmental and Safety Laws. Neither the Company nor any of
its Subsidiaries is in violation of any applicable statute, law or regulation
relating to the environment or occupational health and safety, and to its
knowledge, no material expenditures are or will be required in order to comply
with any such existing statute, law or regulation. Except as set forth on
Schedule 4.17, no Hazardous Materials (as defined below) are used or have been
used, stored, or disposed of by the Company or any of its Subsidiaries or, to
the Company's knowledge, by any other person or entity on any property owned,
leased or used by the Company or any of its Subsidiaries. For the purposes of
the preceding sentence, "Hazardous Materials" shall mean:

            (a) materials which are listed or otherwise defined as "hazardous"
      or "toxic" under any applicable local, state, federal and/or foreign laws
      and regulations that govern the existence and/or remedy of contamination
      on property, the protection of the environment from contamination, the
      control of hazardous wastes, or other activities involving hazardous
      substances, including building materials; or

                                       10
<PAGE>

            (b) any petroleum products or nuclear materials.

            4.18 Valid Offering. Assuming the accuracy of the representations
and warranties of the Purchaser contained in this Agreement, the offer, sale and
issuance of the Securities will be exempt from the registration requirements of
the Securities Act of 1933, as amended (the "Securities Act"), and will have
been registered or qualified (or are exempt from registration and qualification)
under the registration, permit or qualification requirements of all applicable
state securities laws.

            4.19 Full Disclosure. Each of the Company and each of its
Subsidiaries has provided the Purchaser with all information requested by the
Purchaser in connection with its decision to purchase the Note and Warrant,
including all information the Company and its Subsidiaries believe is reasonably
necessary to make such investment decision. Neither this Agreement, the Related
Agreements, the exhibits and schedules hereto and thereto nor any other document
delivered by the Company or any of its Subsidiaries to Purchaser or its
attorneys or agents in connection herewith or therewith or with the transactions
contemplated hereby or thereby, contain any untrue statement of a material fact
nor omit to state a material fact necessary in order to make the statements
contained herein or therein, in light of the circumstances in which they are
made, not misleading. Any financial projections and other estimates provided to
the Purchaser by the Company or any of its Subsidiaries were based on the
Company's and its Subsidiaries' experience in the industry and on assumptions of
fact and opinion as to future events which the Company or any of its
Subsidiaries, at the date of the issuance of such projections or estimates,
believed to be reasonable.

            4.20 Insurance. Each of the Company and each of its Subsidiaries has
general commercial, product liability, fire and casualty insurance policies with
coverages which the Company believes are customary for companies similarly
situated to the Company and its Subsidiaries in the same or similar business.

            4.21 SEC Reports. Except as set forth on Schedule 4.21, the Company
has filed all proxy statements, reports and other documents required to be filed
by it under the Securities Exchange Act 1934, as amended (the "Exchange Act").
The Company has furnished the Purchaser with copies of: (i) its Annual Reports
on Form 10-KSB for its fiscal year ended December 31, 2003; (ii) its Quarterly
Report on Form 10-QSB for its fiscal quarter ended March 31, 2003; (iii) the
Form 8-K filings which it has made during the fiscal year ending December 3,
2004 to date; and (iv) the Definitive Information Statement on Schedule 14C
filed with the SEC on March 22, 2004 (collectively, the "SEC Reports"). Except
as set forth on Schedule 4.21, each SEC Report was, at the time of its filing,
in substantial compliance with the requirements of its respective form and none
of the SEC Reports, nor the financial statements (and the notes thereto)
included in the SEC Reports, as of their respective filing dates, contained any
untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading.

            4.22 No Integrated Offering. Neither the Company, nor any of its
Subsidiaries or affiliates, nor any person acting on its or their behalf, has
directly or indirectly made any offers or sales of any security or solicited any
offers to buy any security under circumstances that would cause the offering of
the Securities pursuant to this Agreement or any of the Related Agreements to be
integrated with prior offerings by the Company for purposes of the Securities
Act which would prevent the Company from selling the Securities pursuant to Rule
506 under the Securities Act, or any applicable exchange-related stockholder
approval provisions, nor will the Company or any of its affiliates or
Subsidiaries take any action or steps that would cause the offering of the
Securities to be integrated with other offerings.

                                       11
<PAGE>

            4.23 Stop Transfer. The Securities are restricted securities as of
the date of this Agreement. Neither the Company nor any of its Subsidiaries will
issue any stop transfer order or other order impeding the sale and delivery of
any of the Securities at such time as the Securities are registered for public
sale or an exemption from registration is available, except as required by state
and federal securities laws.

            4.24 Dilution. The Company specifically acknowledges that its
obligation to issue the shares of Common Stock upon conversion of the Note and
exercise of the Warrant is binding upon the Company and enforceable regardless
of the dilution such issuance may have on the ownership interests of other
shareholders of the Company.

            4.25 Patriot Act. The Company certifies that, to the best of
Company's knowledge, neither the Company nor any of its Subsidiaries has been
designated, and is not owned or controlled, by a "suspected terrorist" as
defined in Executive Order 13224. The Company hereby acknowledges that the
Purchaser seeks to comply with all applicable laws concerning money laundering
and related activities. In furtherance of those efforts, the Company hereby
represents, warrants and agrees that: (i) none of the cash or property that the
Company or any of its Subsidiaries will pay or will contribute to the Purchaser
has been or shall be derived from, or related to, any activity that is deemed
criminal under United States law; and (ii) no contribution or payment by the
Company or any of its Subsidiaries to the Purchaser, to the extent that they are
within the Company's and/or its Subsidiaries' control shall cause the Purchaser
to be in violation of the United States Bank Secrecy Act, the United States
International Money Laundering Control Act of 1986 or the United States
International Money Laundering Abatement and Anti-Terrorist Financing Act of
2001. The Company shall promptly notify the Purchaser if any of these
representations in this Section ceases to be true and accurate regarding the
Company or any of its Subsidiaries. The Company agrees to provide the Purchaser
any additional information regarding the Company or any of its Subsidiaries that
the Purchaser deems necessary or convenient to ensure compliance with all
applicable laws concerning money laundering and similar activities. The Company
understands and agrees that if at any time it is discovered that any of the
foregoing representations in this Section are incorrect, or if otherwise
required by applicable law or regulation related to money laundering similar
activities, the Purchaser may undertake appropriate actions to ensure compliance
with applicable law or regulation, including but not limited to segregation
and/or redemption of the Purchaser's investment in the Company. The Company
further understands that the Purchaser may release confidential information
about the Company and its Subsidiaries and, if applicable, any underlying
beneficial owners, to proper authorities if the Purchaser, in its sole
discretion, determines that it is in the best interests of the Purchaser in
light of relevant rules and regulations under the laws set forth in subsection
(ii) above.

                                       12
<PAGE>

            4.26 The Company will at all times have authorized and reserved a
sufficient number of shares of Common Stock for the full conversion of the
Warrant and the Note issued hereunder.

            4.27 The Common Stock of the Company is, as of the date hereof,
traded on the Pink Sheets and satisfies all requirements for the continuation of
such trading. The Company has not received any notice that its Common Stock will
be ineligible to be traded on the Pink Sheets or that the Common Stock does not
meet all requirements for the continuation of such trading. The Company hereby
certifies that as of the date hereof it meets or exceeds all eligibility
requirements to have its shares listed for trading on the NASD Over the Counter
Bulletin Board ("OTCBB") and shall secure the listing of its Common Stock on the
OTCBB within 60 days from the date hereof.

      5. Representations and Warranties of the Purchaser. The Purchaser hereby
represents and warrants to the Company as follows (such representations and
warranties do not lessen or obviate the representations and warranties of the
Company set forth in this Agreement):

            5.1 No Shorting. Neither the Purchaser nor any of its affiliates or
investment partners has engaged in "short sales" of the Company's Common Stock,
and neither the Purchaser nor any of its affiliates will, or cause any person or
entity, directly or indirectly, to, engage in "short sales" of the Company's
Common Stock as long as the Note shall be outstanding.

            5.2 Requisite Power and Authority. The Purchaser has all necessary
power and authority under all applicable provisions of law to execute and
deliver this Agreement and the Related Agreements and to carry out their
provisions. All corporate action on Purchaser's part required for the lawful
execution and delivery of this Agreement and the Related Agreements have been or
will be effectively taken prior to the Closing. Upon their execution and
delivery, this Agreement and the Related Agreements will be valid and binding
obligations of Purchaser, enforceable in accordance with their terms, except:

            (a) as limited by applicable bankruptcy, insolvency, reorganization,
      moratorium or other laws of general application affecting enforcement of
      creditors' rights; and

            (b) as limited by general principles of equity that restrict the
      availability of equitable and legal remedies.

            5.3 Investment Representations. Purchaser understands that the
Securities are being offered and sold pursuant to an exemption from registration
contained in the Securities Act based in part upon Purchaser's representations
contained in the Agreement, including, without limitation, that the Purchaser is
an "accredited investor" within the meaning of Regulation D under the Securities
Act of 1933, as amended (the "Securities Act"). The Purchaser confirms that it
has received or has had full access to all the information it considers
necessary or appropriate to make an informed investment decision with respect to
the Note and the Warrant to be purchased by it under this Agreement and the Note
Shares and the Warrant Shares acquired by it upon the conversion of the Note and
the exercise of the Warrant, respectively. The Purchaser further confirms that
it has had an opportunity to ask questions and receive answers from the Company
regarding the Company's and its Subsidiaries' business, management and financial
affairs and the terms and conditions of the Offering, the Note, the Warrant and
the Securities and to obtain additional information (to the extent the Company
possessed such information or could acquire it without unreasonable effort or
expense) necessary to verify any information furnished to the Purchaser or to
which the Purchaser had access.

                                       13
<PAGE>

            5.4 Purchaser Bears Economic Risk. The Purchaser has substantial
experience in evaluating and investing in private placement transactions of
securities in companies similar to the Company so that it is capable of
evaluating the merits and risks of its investment in the Company and has the
capacity to protect its own interests. The Purchaser must bear the economic risk
of this investment until the Securities are sold pursuant to: (i) an effective
registration statement under the Securities Act; or (ii) an exemption from
registration is available with respect to such sale.

            5.5 Acquisition for Own Account. The Purchaser is acquiring the Note
and Warrant and the Note Shares and the Warrant Shares for the Purchaser's own
account for investment only, and not as a nominee or agent and not with a view
towards or for resale in connection with their distribution.

            5.6 Purchaser Can Protect Its Interest. The Purchaser represents
that by reason of its, or of its management's, business and financial
experience, the Purchaser has the capacity to evaluate the merits and risks of
its investment in the Note, the Warrant and the Securities and to protect its
own interests in connection with the transactions contemplated in this Agreement
and the Related Agreements. Further, Purchaser is aware of no publication of any
advertisement in connection with the transactions contemplated in the Agreement
or the Related Agreements.

            5.7 Accredited Investor. Purchaser represents that it is an
accredited investor within the meaning of Regulation D under the Securities Act.

            5.8 Legends.

            (a) The Note shall bear substantially the following legend:

                  "THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF
                  THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
                  1933, AS AMENDED, OR ANY APPLICABLE, STATE SECURITIES LAWS.
                  THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF
                  THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR
                  HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
                  STATEMENT AS TO THIS NOTE OR SUCH SHARES UNDER SAID ACT AND
                  APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL
                  REASONABLY SATISFACTORY TO GVI SECURITY SOLUTIONS, INC. THAT
                  SUCH REGISTRATION IS NOT REQUIRED."

                                       14
<PAGE>

            (b) The Note Shares and the Warrant Shares, if not issued by DWAC
      system (as hereinafter defined), shall bear a legend which shall be in
      substantially the following form until such shares are covered by an
      effective registration statement filed with the SEC:

                  "THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
                  REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
                  ANY APPLICABLE STATE SECURITIES LAWS. THESE SHARES MAY NOT BE
                  SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE
                  OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH SECURITIES
                  ACT AND APPLICABLE STATE LAWS OR AN OPINION OF COUNSEL
                  REASONABLY SATISFACTORY TO GVI SECURITY SOLUTIONS, INC. THAT
                  SUCH REGISTRATION IS NOT REQUIRED."

            (c) The Warrant shall bear substantially the following legend:

                  "THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF
                  THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
                  OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS.
                  THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF
                  THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR
                  HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
                  STATEMENT AS TO THIS WARRANT OR THE UNDERLYING SHARES OF
                  COMMON STOCK UNDER SAID ACT AND APPLICABLE STATE SECURITIES
                  LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO GVI
                  SECURITY SOLUTIONS, INC. THAT SUCH REGISTRATION IS NOT
                  REQUIRED."

      6. Covenants of the Company. The Company covenants and agrees with the
Purchaser as follows:

            6.1 Stop-Orders. The Company will advise the Purchaser, promptly
after it receives notice of issuance by the Securities and Exchange Commission
(the "SEC"), any state securities commission or any other regulatory authority
of any stop order or of any order preventing or suspending any offering of any
securities of the Company, or of the suspension of the qualification of the
Common Stock of the Company for offering or sale in any jurisdiction, or the
initiation of any proceeding for any such purpose.

            6.2 Listing. The Common Stock of the Company is, as of the date
hereof, traded on the Pink Sheets and satisfies all requirements for the
continuation of such trading. The Company has not received any notice that its
common stock will be ineligible to be traded on the Pink Sheets or that the
Common Stock does not meet all requirements for the continuation of such
trading. The Company hereby certifies that as of the date hereof it meets or
exceeds all eligibility requirements to have its shares listed for trading on
the NASD Over the Counter Bulletin Board ("OTCBB") and shall secure the listing
of its Common Stock on the NASD Over the Counter Bulletin Board ("OTCBB") within
60 days from the date hereof.

                                       15
<PAGE>

            6.3 Market Regulations. To the extent applicable, the Company shall
notify the SEC, NASD and applicable state authorities, in accordance with their
requirements, of the transactions contemplated by this Agreement, and shall take
all other necessary action and proceedings as may be required and permitted by
applicable law, rule and regulation, for the legal and valid issuance of the
Securities to the Purchaser and promptly provide copies thereof to the
Purchaser.

            6.4 Reporting Requirements. The Company will timely file with the
SEC all reports required to be filed pursuant to the Exchange Act and refrain
from terminating its status as an issuer required by the Exchange Act to file
reports thereunder even if the Exchange Act or the rules or regulations
thereunder would permit such termination.

            6.5 Use of Funds. The Company agrees that it will use the proceeds
of the sale of the Note and the Warrant for general working capital purposes and
as otherwise set forth on Schedule 6.5.

            6.6 Access to Facilities. Each of the Company and each of its
Subsidiaries will permit any representatives designated by the Purchaser (or any
successor of the Purchaser), upon reasonable notice and during normal business
hours, at such person's expense and accompanied by a representative of the
Company, to:

            (a) visit and inspect any of the properties of the Company or any of
      its Subsidiaries;

            (b) examine the corporate and financial records of the Company or
      any of its Subsidiaries (unless such examination is not permitted by
      federal, state or local law or by contract) and make copies thereof or
      extracts therefrom; and

            (c) discuss the affairs, finances and accounts of the Company or any
      of its Subsidiaries with the directors, officers and independent
      accountants of the Company or any of its Subsidiaries.

Notwithstanding the foregoing, neither the Company nor any of its Subsidiaries
will provide any material, non-public information to the Purchaser unless the
Purchaser signs a confidentiality agreement and otherwise complies with
Regulation FD, under the federal securities laws.

            6.7 Taxes. Each of the Company and each of its Subsidiaries will
promptly pay and discharge, or cause to be paid and discharged, when due and
payable, all lawful taxes, assessments and governmental charges or levies
imposed upon the income, profits, property or business of the Company and its
Subsidiaries; provided, however, that any such tax, assessment, charge or levy
need not be paid if the validity thereof shall currently be contested in good
faith by appropriate proceedings and if the Company and/or such Subsidiary shall
have set aside on its books adequate reserves with respect thereto, and
provided, further, that the Company and its Subsidiaries will pay all such
taxes, assessments, charges or levies forthwith upon the commencement of
proceedings to foreclose any lien which may have attached as security therefor.

                                       16
<PAGE>

            6.8 Insurance. Each of the Company and its Subsidiaries will keep
its assets which are of an insurable character insured by financially sound and
reputable insurers against loss or damage by fire, explosion and other risks
customarily insured against by companies in similar business similarly situated
as the Company and its Subsidiaries; and the Company and its Subsidiaries will
maintain, with financially sound and reputable insurers, insurance against other
hazards and risks and liability to persons and property to the extent and in the
manner which the Company reasonably believes is customary for companies in
similar business similarly situated as the Company and its Subsidiaries and to
the extent available on commercially reasonable terms. The Company, and each of
its Subsidiaries will jointly and severally bear the full risk of loss from any
loss of any nature whatsoever with respect to the assets pledged to the
Purchaser as security for its obligations hereunder and under the Related
Agreements. At the Company's and each of its Subsidiaries' joint and several
cost and expense in amounts and with carriers reasonably acceptable to
Purchaser, the Company and each of its Subsidiaries shall (i) keep all its
insurable properties and properties in which it has an interest insured against
the hazards of fire, flood, sprinkler leakage, those hazards covered by extended
coverage insurance and such other hazards, and for such amounts, as is customary
in the case of companies engaged in businesses similar to the Company's or the
respective Subsidiary's including business interruption insurance; (ii) maintain
a bond in such amounts as is customary in the case of companies engaged in
businesses similar to the Company's or the respective Subsidiary's insuring
against larceny, embezzlement or other criminal misappropriation of insured's
officers and employees who may either singly or jointly with others at any time
have access to the assets or funds of the Company or any of its Subsidiaries
either directly or through governmental authority to draw upon such funds or to
direct generally the disposition of such assets; (iii) maintain public and
product liability insurance against claims for personal injury, death or
property damage suffered by others; (iv) maintain all such worker's compensation
or similar insurance as may be required under the laws of any state or
jurisdiction in which the Company or the respective Subsidiary is engaged in
business; and (v) furnish Purchaser with (x) copies of all policies and evidence
of the maintenance of such policies at least thirty (30) days before any
expiration date, (y) excepting the Company's workers' compensation policy,
endorsements to such policies naming Purchaser as "co-insured" or "additional
insured" and appropriate loss payable endorsements in form and substance
satisfactory to Purchaser, naming Purchaser as loss payee, and (z) evidence that
as to Purchaser the insurance coverage shall not be impaired or invalidated by
any act or neglect of the Company or any Subsidiary and the insurer will provide
Purchaser with at least thirty (30) days notice prior to cancellation. The
Company and each Subsidiary shall instruct the insurance carriers that in the
event of any loss thereunder, the carriers shall make payment for such loss to
the Company and/or the Subsidiary and Purchaser jointly. In the event that as of
the date of receipt of each loss recovery upon any such insurance, the Purchaser
has not declared an event of default with respect to this Agreement or any of
the Related Agreements, then the Company and/or such Subsidiary shall be
permitted to direct the application of such loss recovery proceeds toward
investment in property, plant and equipment that would comprise "Collateral"
secured by Purchaser's security interest pursuant to its security agreement. In
the event that Purchaser has properly declared an Event of Default with respect
to this Agreement or any of the Related Agreements, then all loss recoveries
received by Purchaser upon any such insurance thereafter may be applied to the
obligations of the Company hereunder and under the Related Agreements, in such
order as the Purchaser may determine. Any surplus (following satisfaction of all
Company obligations to Purchaser) shall be paid by Purchaser to the Company or
applied as may be otherwise required by law. Any deficiency thereon shall be
paid by the Company or the Subsidiary, as applicable, to Purchaser, on demand.

                                       17
<PAGE>

            6.9 Intellectual Property. Each of the Company and each of its
Subsidiaries shall maintain in full force and effect its existence, rights and
franchises and all licenses and other rights to use Intellectual Property owned
or possessed by it and reasonably deemed to be necessary to the conduct of its
business.

            6.10 Properties. Each of the Company and each of its Subsidiaries
will keep its properties in good repair, working order and condition, reasonable
wear and tear excepted, and from time to time make all needful and proper
repairs, renewals, replacements, additions and improvements thereto; and each of
the Company and each of its Subsidiaries will at all times comply with each
provision of all leases to which it is a party or under which it occupies
property if the breach of such provision could, either individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect.

            6.11 Confidentiality. Other than in reports the Company may file
with the SEC, the Company agrees that it will not disclose, and will not include
in any public announcement, the name of the Purchaser, unless expressly agreed
to by the Purchaser or unless and until such disclosure is required by law or
applicable regulation, and then only to the extent of such requirement.
Notwithstanding the foregoing, the Company may disclose Purchaser's identity and
the terms of this Agreement to its current and prospective debt and equity
financing sources.

            6.12 Required Approvals. For so long as twenty-five percent (25%) of
the principal amount of the Note is outstanding, the Company, without the prior
written consent of the Purchaser, shall not, and shall not permit any of its
Subsidiaries to:

            (a) directly or indirectly declare or pay any dividends, other than
      dividends paid to the Company or any of its wholly-owned Subsidiaries;

            (b) liquidate, dissolve or effect a material reorganization (it
      being understood that in no event shall the Company dissolve, liquidate or
      merge with any other person or entity (unless the Company is the surviving
      entity);

            (c) become subject to (including, without limitation, by way of
      amendment to or modification of) any agreement or instrument which by its
      terms would (under any circumstances) restrict the Company's or any of its
      Subsidiaries right to perform the provisions of this Agreement, any
      Related Agreement or any of the agreements contemplated hereby or thereby;

            (d) materially alter or change the scope of the business of the
      Company and its Subsidiaries taken as a whole;

                                       18
<PAGE>

            (e) (i) create, incur, assume or suffer to exist any indebtedness
      for borrowed money (exclusive of trade debt and debt incurred to finance
      the purchase of equipment (not in excess of five percent (5%) per annum of
      the fair market value of the Company's assets)) whether secured or
      unsecured, other than (w) the Company's indebtedness to Purchaser, (x)
      debt subordinated to the Company's indebtedness to Purchaser, (y)
      indebtedness set forth on Schedule 6.12(e) attached hereto and made a part
      hereof and any refinancings or replacements thereof on
      terms no less favorable to the Purchaser than the indebtedness being
      refinanced or replaced, and (z) any debt incurred in connection with the
      purchase of assets in the ordinary course of business, or any refinancings
      or replacements thereof on terms no less favorable to the Purchaser than
      the indebtedness being refinanced or replaced; (ii) cancel any debt owing
      to it in excess of $50,000 in the aggregate during any 12 month period;
      (iii) assume, guarantee, endorse or otherwise become directly or
      contingently liable in connection with any obligations of any other
      Person, except the endorsement of negotiable instruments by the Company
      for deposit or collection or similar transactions in the ordinary course
      of business or guarantees of indebtedness otherwise permitted to be
      outstanding pursuant to this clause (e); and

            (f) create or acquire any Subsidiary after the date hereof unless
      (i) such Subsidiary is a wholly-owned Subsidiary of the Company and (ii)
      such Subsidiary becomes party to the Master Security Agreement and the
      Subsidiary Guaranty (either by executing a counterpart thereof or an
      assumption or joinder agreement in respect thereof) and, to the extent
      required by the Purchaser, satisfies each condition of this Agreement and
      the Related Agreements as if such Subsidiary were a Subsidiary on the
      Closing Date.

            6.13 Reissuance of Securities. The Company agrees to reissue
certificates representing the Securities without the legends set forth in
Section 5.7 above at such time as:

            (a) the holder thereof is permitted to dispose of such Securities
      pursuant to Rule 144(k) under the Securities Act; or

            (b) upon resale subject to an effective registration statement after
      such Securities are registered under the Securities Act.

The Company agrees to cooperate with the Purchaser in connection with all
resales pursuant to Rule 144(d) and Rule 144(k) and provide legal opinions
necessary to allow such resales provided the Company and its counsel receive
reasonably requested representations from the selling Purchaser and broker, if
any.

            6.14 Opinion. On the Closing Date, the Company will deliver to the
Purchaser an opinion acceptable to the Purchaser from the Company's external
legal counsel. The Company will provide, at the Company's expense, such other
legal opinions in the future as are deemed reasonably necessary by the Purchaser
(and acceptable to the Purchaser) in connection with the issuance of Common
Stock upon conversion of the Note and exercise of the Warrant.

            6.15 Margin Stock. The Company will not permit any of the proceeds
of the Note or the Warrant to be used directly or indirectly to "purchase" or
"carry" "margin stock" or to repay indebtedness incurred to "purchase" or
"carry" "margin stock" within the respective meanings of each of the quoted
terms under Regulation U of the Board of Governors of the Federal Reserve System
as now and from time to time hereafter in effect.

                                       19
<PAGE>

      7. Covenants of the Purchaser. The Purchaser covenants and agrees with the
Company as follows:

            7.1 Confidentiality. The Purchaser agrees that it will not disclose,
and will not include in any public announcement, the name of the Company, unless
expressly agreed to by the Company or unless and until such disclosure is
required by law or applicable regulation, and then only to the extent of such
requirement.

            7.2 No Short Sales. Neither the Purchaser nor any of its affiliates
will, or cause any person or entity, directly or indirectly, to, engage in
"short sales" of the Company's Common Stock as long as the Note shall be
outstanding.

            7.3 Non-Public Information. The Purchaser agrees not to effect any
sales in the shares of the Company's Common Stock while in possession of
material, non-public information regarding the Company if such sales would
violate applicable securities law.

      8. Covenants of the Company and Purchaser Regarding Indemnification.

            8.1 Company Indemnification. The Company agrees to indemnify, hold
harmless, reimburse and defend the Purchaser, each of the Purchaser's officers,
directors, agents, affiliates, control persons, and principal shareholders,
against any claim, cost, expense, liability, obligation, loss or damage
(including reasonable legal fees) of any nature, incurred by or imposed upon the
Purchaser which results, arises out of or is based upon: (i) any material
misrepresentation by the Company or any of its Subsidiaries or breach in any
material respect of any warranty by the Company or any of its Subsidiaries in
this Agreement, any other Related Agreement or in any exhibits or schedules
attached hereto or thereto; or (ii) any breach or default in performance by
Company or any of its Subsidiaries of any covenant or undertaking to be
performed by Company or any of its Subsidiaries hereunder in any material
respect, under any other Related Agreement or any other agreement entered into
by the Company and/or any of its Subsidiaries and Purchaser relating hereto or
thereto.

            8.2 Purchaser's Indemnification. Purchaser agrees to indemnify, hold
harmless, reimburse and defend the Company and each of the Company's officers,
directors, agents, affiliates, control persons and principal shareholders, at
all times against any claim, cost, expense, liability, obligation, loss or
damage (including reasonable legal fees) of any nature, incurred by or imposed
upon the Company which results, arises out of or is based upon: (i) any
misrepresentation by Purchaser or breach of any warranty by Purchaser in this
Agreement or in any exhibits or schedules attached hereto or any Related
Agreement; or (ii) any breach or default in performance by Purchaser of any
covenant or undertaking to be performed by Purchaser hereunder, or any other
agreement entered into by the Company and Purchaser relating hereto.

      9. Conversion of Convertible Note.

            9.1 Mechanics of Conversion.

                                       20
<PAGE>

            (a) Provided the Purchaser has notified the Company of the
      Purchaser's intention to sell the Note Shares and the Note Shares are
      included in an effective registration statement or are otherwise exempt
      from registration when sold: (i) upon the conversion of the Note or part
      thereof, the Company shall, at its own cost and expense, take all
      necessary action (including the issuance of an opinion of counsel
      reasonably acceptable to the Purchaser following a request by the
      Purchaser) to assure that the Company's transfer agent shall issue shares
      of the Company's Common Stock in the name of the Purchaser (or its
      nominee) or such other persons as designated by the Purchaser in
      accordance with Section 9.1(b) hereof and in such denominations to be
      specified representing the number of Note Shares issuable upon such
      conversion; and (ii) the Company warrants that no instructions other than
      these instructions have been or will be given to the transfer agent of the
      Company's Common Stock and that after the Effectiveness Date (as defined
      in the Registration Rights Agreement) the Note Shares issued will be
      freely transferable subject to the prospectus delivery requirements of the
      Securities Act and the provisions of this Agreement, and will not contain
      a legend restricting the resale or transferability of the Note Shares.

            (b) Purchaser will give notice of its decision to exercise its right
      to convert the Note or part thereof by telecopying or otherwise delivering
      an executed and completed notice of the number of shares to be converted
      to the Company (the "Notice of Conversion") in accordance with the Note.
      The Purchaser will not be required to surrender the Note until the
      Purchaser receives either a certificate for the Note Shares or a credit to
      the account of the Purchaser's prime broker through the DWAC system (as
      defined in the Note), representing the Note Shares or until the Note has
      been fully satisfied.

Nothing contained herein or in any document referred to herein or delivered in
connection herewith shall be deemed to establish or require the payment of a
rate of interest or other charges in excess of the maximum permitted by
applicable law. In the event that the rate of interest or dividends required to
be paid or other charges hereunder exceed the maximum amount permitted by such
law, any payments in excess of such maximum shall be credited against amounts
owed by the Company to a Purchaser and thus refunded to the Company.

      10. Registration Rights.

            10.1 Registration Rights Granted. The Company has granted
registration rights to the Purchaser pursuant to a Registration Rights Agreement
dated as of even date herewith between the Company and the Purchaser.

            10.2 Offering Restrictions. Except as previously disclosed in the
SEC Reports or in the Exchange Act Filings, or stock or stock options granted to
employees or directors of the Company (these exceptions hereinafter referred to
as the "Excepted Issuances"), neither the Company nor any of its Subsidiaries
will issue any securities with a continuously variable/floating conversion
feature which are or could be (by conversion or registration) free-trading
securities (i.e. common stock subject to a registration statement) prior to the
full repayment or conversion of the Note (together with all accrued and unpaid
interest and fees related thereto).

                                       21
<PAGE>

      11. Miscellaneous.

            11.1 Governing Law. THIS AGREEMENT AND EACH RELATED AGREEMENT SHALL
BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW
YORK, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAWS. ANY ACTION BROUGHT BY
EITHER PARTY AGAINST THE OTHER CONCERNING THE TRANSACTIONS CONTEMPLATED BY THIS
AGREEMENT AND EACH RELATED AGREEMENT SHALL BE BROUGHT ONLY IN THE STATE COURTS
OF NEW YORK OR IN THE FEDERAL COURTS LOCATED IN THE STATE OF NEW YORK. BOTH
PARTIES AND THE INDIVIDUALS EXECUTING THIS AGREEMENT AND THE RELATED AGREEMENTS
ON BEHALF OF THE COMPANY AGREE TO SUBMIT TO THE JURISDICTION OF SUCH COURTS AND
WAIVE TRIAL BY JURY. IN THE EVENT THAT ANY PROVISION OF THIS AGREEMENT OR ANY
RELATED AGREEMENT DELIVERED IN CONNECTION HEREWITH IS INVALID OR UNENFORCEABLE
UNDER ANY APPLICABLE STATUTE OR RULE OF LAW, THEN SUCH PROVISION SHALL BE DEEMED
INOPERATIVE TO THE EXTENT THAT IT MAY CONFLICT THEREWITH AND SHALL BE DEEMED
MODIFIED TO CONFORM WITH SUCH STATUTE OR RULE OF LAW. ANY SUCH PROVISION WHICH
MAY PROVE INVALID OR UNENFORCEABLE UNDER ANY LAW SHALL NOT AFFECT THE VALIDITY
OR ENFORCEABILITY OF ANY OTHER PROVISION OF THIS AGREEMENT OR ANY RELATED
AGREEMENT.

            11.2 Survival. The representations, warranties, covenants and
agreements made herein shall survive any investigation made by the Purchaser and
the closing of the transactions contemplated hereby to the extent provided
therein. All statements as to factual matters contained in any certificate or
other instrument delivered by or on behalf of the Company pursuant hereto in
connection with the transactions contemplated hereby shall be deemed to be
representations and warranties by the Company hereunder solely as of the date of
such certificate or instrument.

            11.3 Successors. Except as otherwise expressly provided herein, the
provisions hereof shall inure to the benefit of, and be binding upon, the
successors, heirs, executors and administrators of the parties hereto and shall
inure to the benefit of and be enforceable by each person who shall be a holder
of the Securities from time to time, other than the holders of Common Stock
which has been sold by the Purchaser pursuant to Rule 144 or an effective
registration statement. Purchaser may not assign its rights hereunder to a
competitor of the Company.

            11.4 Entire Agreement. This Agreement, the Related Agreements, the
exhibits and schedules hereto and thereto and the other documents delivered
pursuant hereto constitute the full and entire understanding and agreement
between the parties with regard to the subjects hereof and no party shall be
liable or bound to any other in any manner by any representations, warranties,
covenants and agreements except as specifically set forth herein and therein.

            11.5 Severability. In case any provision of the Agreement shall be
invalid, illegal or unenforceable, the validity, legality and enforceability of
the remaining provisions shall not in any way be affected or impaired thereby.

                                       22
<PAGE>

            11.6 Amendment and Waiver.

            (a) This Agreement may be amended or modified only upon the written
      consent of the Company and the Purchaser.

            (b) The obligations of the Company and the rights of the Purchaser
      under this Agreement may be waived only with the written consent of the
      Purchaser.

            (c) The obligations of the Purchaser and the rights of the Company
      under this Agreement may be waived only with the written consent of the
      Company.

            11.7 Delays or Omissions. It is agreed that no delay or omission to
exercise any right, power or remedy accruing to any party, upon any breach,
default or noncompliance by another party under this Agreement or the Related
Agreements, shall impair any such right, power or remedy, nor shall it be
construed to be a waiver of any such breach, default or noncompliance, or any
acquiescence therein, or of or in any similar breach, default or noncompliance
thereafter occurring. All remedies, either under this Agreement or the Related
Agreements, by law or otherwise afforded to any party, shall be cumulative and
not alternative.

            11.8 Notices. All notices required or permitted hereunder shall be
in writing and shall be deemed effectively given:

            (a) upon personal delivery to the party to be notified;

            (b) when sent by confirmed facsimile if sent during normal business
      hours of the recipient, if not, then on the next business day;

            (c) three (3) business days after having been sent by registered or
      certified mail, return receipt requested, postage prepaid; or

            (d) one (1) day after deposit with a nationally recognized overnight
      courier, specifying next day delivery, with written verification of
      receipt.

All communications shall be sent as follows:

     If to the Company, to:              GVI Security Solutions, Inc.
                                         1621 West Crosby
                                         Suite 104
                                         Carrollton, TX 75006
                                         Attention: Nazzareno E. Paciotti,
                                                    Chief Financial Officer
                                         Facsimile: 972-245 7333

                                         with a copy to:
                                         Kronish Lieb Weiner & Hellman LLP
                                         1114 Avenue of the Americas
                                         New York, NY 10036
                                         Attention: Alison Newman, Esq.
                                         Facsimile: 212-479-6275

                                       23
<PAGE>

     If to the Purchaser, to:            Laurus Master Fund, Ltd.
                                         c/o Ironshore Corporate Services ltd.
                                         P.O. Box 1234 G.T.
                                         Queensgate House, South Church Street
                                         Grand Cayman, Cayman Islands
                                         Facsimile:........345-949-9877

                                         with a copy to:

                                         John E. Tucker, Esq.
                                         825 Third Avenue 14th Floor
                                         New York, NY 10022
                                         Facsimile:........212-541-4434

or at such other address as the Company or the Purchaser may designate by
written notice to the other parties hereto given in accordance herewith.

            11.9 Attorneys' Fees. In the event that any suit or action is
instituted to enforce any provision in this Agreement, the prevailing party in
such dispute shall be entitled to recover from the losing party all fees, costs
and expenses of enforcing any right of such prevailing party under or with
respect to this Agreement, including, without limitation, such reasonable fees
and expenses of attorneys and accountants, which shall include, without
limitation, all fees, costs and expenses of appeals.

            11.10 Titles and Subtitles. The titles of the sections and
subsections of this Agreement are for convenience of reference only and are not
to be considered in construing this Agreement.

            11.11 Facsimile Signatures; Counterparts. This Agreement may be
executed by facsimile signatures and in any number of counterparts, each of
which shall be an original, but all of which together shall constitute one
instrument.

            11.12 Broker's Fees. Except as set forth on Schedule 11.12 hereof,
each party hereto represents and warrants that no agent, broker, investment
banker, person or firm acting on behalf of or under the authority of such party
hereto is or will be entitled to any broker's or finder's fee or any other
commission directly or indirectly in connection with the transactions
contemplated herein. Each party hereto further agrees to indemnify each other
party for any claims, losses or expenses incurred by such other party as a
result of the representation in this Section 11.12 being untrue.

            11.13 Construction. Each party acknowledges that its legal counsel
participated in the preparation of this Agreement and the Related Agreements
and, therefore, stipulates that the rule of construction that ambiguities are to
be resolved against the drafting party shall not be applied in the
interpretation of this Agreement to favor any party against the other.

                                       24
<PAGE>

             [THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK

                                       25
<PAGE>

      IN WITNESS WHEREOF, the parties hereto have executed the SECURITIES
PURCHASE AGREEMENT as of the date set forth in the first paragraph hereof.

       COMPANY:                           PURCHASER:

       GVI SECURITY SOLUTIONS, INC.       LAURUS MASTER FUND, LTD.

       By:                                By:
              ------------------------           ------------------------
              ------------------------           ------------------------
       Name:                              Name:
              ------------------------           ------------------------
              ------------------------           ------------------------
       Title:                             Title:
              ------------------------           ------------------------

                                       26

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}]]